US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

DRUGS MADE IN AMERICA ACQUISITION II CORP

10.14

0.0000

Volume:1K

Turnover:10.78K

Market Cap:645.92M

PE:49.61

High:10.14

Open:10.14

Low:10.14

Close:10.14

52wk High:10.20

52wk Low:9.86

Shares:63.70M

Float Shares:50.26M

Volume Ratio:0.69

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.2044

EPS(LYR):0.1511

ROE:--

ROA:-0.32%

PB:-36.03

PE(LYR):67.12

Loading ...

Overview Company News Filings

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Major Issues Report

Form 8-K - Current report

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Major Issues Report

Form 8-K - Current report

Correspondence

Form CORRESP - Correspondence

Correspondence

Form CORRESP - Correspondence

Correspondence

Form CORRESP - Correspondence

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933

Correspondence

Form CORRESP - Correspondence

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/DMII/filings"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DMII","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMII\",,,,,undefined,":{"symbol":"DMII","market":"US","secType":"STK","nameCN":"DRUGS MADE IN AMERICA ACQUISITION II CORP","latestPrice":10.14,"timestamp":1787342400000,"preClose":10.14,"halted":0,"volume":1063,"delay":0,"changeRate":0,"floatShares":50258300,"shares":63700000,"eps":0.204375,"marketStatus":"Pre-Mkt","change":0,"latestTime":"08-24 04:32:51 EDT","open":10.14,"high":10.14,"low":10.14,"amount":10779,"amplitude":0,"askPrice":16.24,"askSize":200,"bidPrice":9.21,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.204375,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":10.14,"postHourTrading":{"tag":"盘后","latestPrice":10.15,"preClose":10.14,"latestTime":"16:00 EDT","volume":13,"amount":131.95000000000002,"timestamp":1787342401860,"change":0.01,"changeRate":0.000986,"amplitude":0},"volumeRatio":0.6903494184423112},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMII\",,,,,undefined,":{"symbol":"DMII","floatShares":50258300,"roa":"-0.32%","roe":"--","lyrEps":0.151078,"volumeRatio":0.6903494184423112,"shares":63700000,"dividePrice":0,"high":10.14,"amplitude":0,"preClose":10.14,"low":10.14,"week52Low":9.86,"pbRate":"-36.03","week52High":10.2,"institutionHeld":0,"latestPrice":10.14,"committee":-0.333333,"eps":0.204375,"divideRate":0,"volume":1063,"delay":0,"ttmEps":0.204375,"open":10.14,"prevYearClose":9.9,"prevWeekClose":10.13,"prevMonthClose":10.11,"prevQuarterClose":10.06,"fiveDayClose":10.13,"twentyDayClose":10.1,"sixtyDayClose":10.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMII\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"DMII","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"post","actualEps":null},{"date":"2026-05-14","symbol":"DMII","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1778788800000,"name":null,"time":"Post-Mkt","dateTimestamp":1778731200000,"actualEps":null},{"date":"2026-04-15","symbol":"DMII","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776283200000,"name":null,"time":"Post-Mkt","dateTimestamp":1776225600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMII\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMII\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DMII\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DMII","date":"2026-08-21","current":49.614679,"percent":0.536723,"low":-1442.152378,"twenty":-1436.389532,"median":-1275.121826,"eighty":74.948187,"high":156.692152,"avg":-684.526306,"sd":760.543686,"marketCap":645918000},"quantilePoints":[{"date":"2025-12-05","current":-1128.261237,"twenty":-1127.923771,"median":-1127.417572,"eighty":-1126.911373,"marketCap":513536000},{"date":"2025-12-12","current":-1421.982415,"twenty":-1423.423127,"median":-1421.982415,"eighty":-1187.005473,"marketCap":647225250},{"date":"2025-12-19","current":-1421.982415,"twenty":-1423.423127,"median":-1421.982415,"eighty":-1421.982415,"marketCap":647225250},{"date":"2025-12-26","current":-1426.30455,"twenty":-1423.423127,"median":-1422.702771,"eighty":-1421.982415,"marketCap":649192500},{"date":"2026-01-02","current":-1426.30455,"twenty":-1426.30455,"median":-1423.423127,"eighty":-1421.982415,"marketCap":649192500},{"date":"2026-01-09","current":-1428.465617,"twenty":-1426.30455,"median":-1423.423127,"eighty":-1421.982415,"marketCap":650176125},{"date":"2026-01-16","current":-1432.067397,"twenty":-1428.609688,"median":-1425.584194,"eighty":-1421.982415,"marketCap":651815500},{"date":"2026-01-23","current":-1436.389532,"twenty":-1429.762258,"median":-1426.30455,"eighty":-1421.982415,"marketCap":653782750},{"date":"2026-01-30","current":-1434.94882,"twenty":-1433.508108,"median":-1426.30455,"eighty":-1422.846842,"marketCap":653127000},{"date":"2026-02-06","current":-1442.152378,"twenty":-1434.94882,"median":-1428.10544,"eighty":-1423.423127,"marketCap":656405750},{"date":"2026-02-13","current":-1439.270955,"twenty":-1436.389532,"median":-1429.185973,"eighty":-1423.423127,"marketCap":655094250},{"date":"2026-02-20","current":-1442.152378,"twenty":-1439.270955,"median":-1429.185973,"eighty":-1423.423127,"marketCap":656405750},{"date":"2026-02-27","current":-1437.830243,"twenty":-1439.270955,"median":-1432.067397,"eighty":-1423.423127,"marketCap":654438500},{"date":"2026-03-06","current":-1437.830243,"twenty":-1439.270955,"median":-1433.508108,"eighty":-1423.423127,"marketCap":654438500},{"date":"2026-03-13","current":-1433.464886,"twenty":-1439.270955,"median":-1433.508108,"eighty":-1423.999411,"marketCap":652451577},{"date":"2026-03-20","current":-1434.94882,"twenty":-1438.69467,"median":-1433.508108,"eighty":-1425.440123,"marketCap":653127000},{"date":"2026-03-27","current":-1437.830243,"twenty":-1437.830243,"median":-1434.94882,"eighty":-1426.30455,"marketCap":654438500},{"date":"2026-04-02","current":-1439.270955,"twenty":-1437.830243,"median":-1434.94882,"eighty":-1426.30455,"marketCap":655094250},{"date":"2026-04-10","current":-1439.270955,"twenty":-1439.270955,"median":-1434.94882,"eighty":-1426.30455,"marketCap":655094250},{"date":"2026-04-17","current":156.692152,"twenty":-1439.270955,"median":-1434.94882,"eighty":-1426.30455,"marketCap":656077875},{"date":"2026-04-24","current":152.287888,"twenty":-1439.270955,"median":-1434.94882,"eighty":-1423.711269,"marketCap":637637000},{"date":"2026-05-01","current":152.440023,"twenty":-1439.270955,"median":-1434.94882,"eighty":-1423.423127,"marketCap":638274000},{"date":"2026-05-08","current":152.363956,"twenty":-1439.270955,"median":-1433.508108,"eighty":-1421.982415,"marketCap":637955500},{"date":"2026-05-15","current":152.592159,"twenty":-1439.270955,"median":-1433.508108,"eighty":-1187.005473,"marketCap":638911000},{"date":"2026-05-22","current":74.577156,"twenty":-1438.982813,"median":-1433.464886,"eighty":74.488109,"marketCap":640185000},{"date":"2026-05-29","current":74.725568,"twenty":-1437.830243,"median":-1432.067397,"eighty":74.651362,"marketCap":641459000},{"date":"2026-06-05","current":74.725568,"twenty":-1437.830243,"median":-1431.347041,"eighty":74.725568,"marketCap":641459000},{"date":"2026-06-12","current":74.799775,"twenty":-1437.830243,"median":-1429.185973,"eighty":74.725568,"marketCap":642096000},{"date":"2026-06-18","current":74.948187,"twenty":-1437.830243,"median":-1428.465617,"eighty":74.799775,"marketCap":643370000},{"date":"2026-06-26","current":74.725568,"twenty":-1437.830243,"median":-1427.024906,"eighty":74.799775,"marketCap":641459000},{"date":"2026-07-02","current":74.725568,"twenty":-1437.830243,"median":-1426.30455,"eighty":74.799775,"marketCap":641459000},{"date":"2026-07-10","current":74.948187,"twenty":-1437.830243,"median":-1426.30455,"eighty":74.873536,"marketCap":643370000},{"date":"2026-07-17","current":74.873981,"twenty":-1437.830243,"median":-1424.143483,"eighty":74.873981,"marketCap":642733000},{"date":"2026-07-24","current":74.873981,"twenty":-1437.830243,"median":-1423.423127,"eighty":74.873981,"marketCap":642733000},{"date":"2026-07-31","current":75.096599,"twenty":-1437.830243,"median":-1423.423127,"eighty":74.896243,"marketCap":644644000},{"date":"2026-08-07","current":75.022393,"twenty":-1437.253959,"median":-1421.982415,"eighty":74.948187,"marketCap":644007000},{"date":"2026-08-14","current":75.170805,"twenty":-1436.389532,"median":-1421.982415,"eighty":74.970449,"marketCap":645281000},{"date":"2026-08-21","current":49.614532,"twenty":-1436.389532,"median":-1275.121826,"eighty":74.948187,"marketCap":645918000}],"updateTime":1787550433200},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"DMII\",pageSize:20,pageCount:1,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"21621447","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026090017-DMII","pdf_url":"","pub_time":1786680000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"DMII","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026090017/0001213900-26-090017-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026090017/ea0301690-10q_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea0301690-10q_drugs2.htm","type":"10-Q","id":"NTFILEG1DuussthVY5syPn","market":"us","size":470401},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026090017/ea030169001ex31-1.htm","primary":false,"translateUrl":"","linkName":"ea030169001ex31-1.htm","type":"EX-31.1","id":"NTFILEFTLNdqp4xU1ttKHb","market":"us","size":11762},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026090017/ea030169001ex31-2.htm","primary":false,"translateUrl":"","linkName":"ea030169001ex31-2.htm","type":"EX-31.2","id":"NTFILEGUr2BgLGrD7eRwXQ","market":"us","size":11799},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026090017/ea030169001ex32-1.htm","primary":false,"translateUrl":"","linkName":"ea030169001ex32-1.htm","type":"EX-32.1","id":"NTFILEGNrG4tQd21Xa6YEg","market":"us","size":4576},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026090017/ea030169001ex32-2.htm","primary":false,"translateUrl":"","linkName":"ea030169001ex32-2.htm","type":"EX-32.2","id":"NTFILEFd4dV6wtjDcPated","market":"us","size":4990}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2026-08-14 12:00","pubTimestamp":1786680000,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21260130","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026056651-DMII","pdf_url":"","pub_time":1778731200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"DMII","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026056651/0001213900-26-056651-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026056651/ea0290022-10q_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea0290022-10q_drugs2.htm","type":"10-Q","id":"NTFILEAnspK2RFBJabmQQa","market":"us","size":410233},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026056651/ea029002201ex31-1.htm","primary":false,"translateUrl":"","linkName":"ea029002201ex31-1.htm","type":"EX-31.1","id":"NTFILE3YPAar8zbHwPBTtm","market":"us","size":18287},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026056651/ea029002201ex31-2.htm","primary":false,"translateUrl":"","linkName":"ea029002201ex31-2.htm","type":"EX-31.2","id":"NTFILEC2ZYDXtPBqUDuRxt","market":"us","size":18301},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026056651/ea029002201ex32-1.htm","primary":false,"translateUrl":"","linkName":"ea029002201ex32-1.htm","type":"EX-32.1","id":"NTFILE79d3QnatCi3h8kA2","market":"us","size":7363},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026056651/ea029002201ex32-2.htm","primary":false,"translateUrl":"","linkName":"ea029002201ex32-2.htm","type":"EX-32.2","id":"NTFILE2vvoCAp87FWrE8VS","market":"us","size":7383}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2026-05-14 12:00","pubTimestamp":1778731200,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21169870","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026048687-DMII","pdf_url":"","pub_time":1777348800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMII","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026048687/0001213900-26-048687-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"STATEMENT OF WORK BETWEEN AND BY DRUGS MADE IN AMERICA ACQUISITION II CORP. AND","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026048687/ea028797501ex10-1.htm","primary":true,"translateUrl":"","linkName":"ea028797501ex10-1.htm","type":"EX-10.1","id":"NTFILE9dv99ckJs85Sjdpt","market":"us","size":12097},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026048687/ea0287975-8k_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea0287975-8k_drugs2.htm","type":"8-K","id":"NTFILE5o9J8qVUPv11BnEx","market":"us","size":39585},{"description":"CEO COMPENSATION AGREEMENT BETWEEN AND BY DRUGS MADE IN AMERICA ACQUISITION II C","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026048687/ea028797501ex10-2.htm","primary":false,"translateUrl":"","linkName":"ea028797501ex10-2.htm","type":"EX-10.2","id":"NTFILE3873M72KNy4fd5LQ","market":"us","size":10598},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026048687/ea028797501_ex10-1img1.jpg","primary":false,"translateUrl":"","linkName":"ea028797501_ex10-1img1.jpg","type":"GRAPHIC","id":"NTFILEE9VYDoyfJgmrpwv7","market":"us","size":3094}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2026-04-28 12:00","pubTimestamp":1777348800,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21007595","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026044055-DMII","pdf_url":"","pub_time":1776225600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"DMII","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"Annual Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/0001213900-26-044055-index.htm","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea0285468-10k_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea0285468-10k_drugs2.htm","type":"10-K","id":"NTFILEHizYowV9hwVaRDbq","market":"us","size":934855},{"description":"DESCRIPTION OF THE COMPANY'S SECURITIES","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea028546801ex4-5.htm","primary":false,"translateUrl":"","linkName":"ea028546801ex4-5.htm","type":"EX-4.5","id":"NTFILEFqvi2hZi25n3ykfQ","market":"us","size":70211},{"description":"INSIDER TRADING POLICY","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea028546801ex-19.htm","primary":false,"translateUrl":"","linkName":"ea028546801ex-19.htm","type":"EX-19","id":"NTFILEGbJV4DDXDQ8ME17b","market":"us","size":40514},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea028546801ex31-1.htm","primary":false,"translateUrl":"","linkName":"ea028546801ex31-1.htm","type":"EX-31.1","id":"NTFILEDUWC6FBUNdx7tA2S","market":"us","size":9116},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea028546801ex31-2.htm","primary":false,"translateUrl":"","linkName":"ea028546801ex31-2.htm","type":"EX-31.2","id":"NTFILE2vot9kPGo21P4ApY","market":"us","size":9271},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea028546801ex32-1.htm","primary":false,"translateUrl":"","linkName":"ea028546801ex32-1.htm","type":"EX-32.1","id":"NTFILE4rebgbj7hwrh4QF5","market":"us","size":3371},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea028546801ex32-2.htm","primary":false,"translateUrl":"","linkName":"ea028546801ex32-2.htm","type":"EX-32.2","id":"NTFILEGJcSuvMmE7ALhxU1","market":"us","size":3337},{"description":"CLAWBACK POLICY","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026044055/ea028546801ex97-1.htm","primary":false,"translateUrl":"","linkName":"ea028546801ex97-1.htm","type":"EX-97.1","id":"NTFILENrzu28E1ds7aHuwA","market":"us","size":24966}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Annual Report","pubTime":"2026-04-15 12:00","pubTimestamp":1776225600,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20960867","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026039986-DMII","pdf_url":"","pub_time":1775188800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMII","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026039986/0001213900-26-039986-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"DEFINITIVE INVESTMENT AND SPONSOR TRANSITION AGREEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026039986/ea028511201ex10-1.htm","primary":true,"translateUrl":"","linkName":"ea028511201ex10-1.htm","type":"EX-10.1","id":"NTFILEF3xXzpbRYhqbaZqg","market":"us","size":36711},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026039986/ea0285112-8k_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea0285112-8k_drugs2.htm","type":"8-K","id":"NTFILE3QRJzhi4tv7wreso","market":"us","size":35545},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026039986/ea028511201_ex10-1img1.jpg","primary":false,"translateUrl":"","linkName":"ea028511201_ex10-1img1.jpg","type":"GRAPHIC","id":"NTFILE2yfEY9UFTQ4fwSRs","market":"us","size":2446}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2026-04-03 12:00","pubTimestamp":1775188800,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20848755","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026029050-DMII","pdf_url":"","pub_time":1773777668000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMII","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/0001213900-26-029050-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"LETTER OF INTENT DATED MARCH 5, 2026 BETWEEN DRUGS MADE IN AMERICA ACQUISITION I","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026029050/ea028195901ex10-1.htm","primary":true,"translateUrl":"","linkName":"ea028195901ex10-1.htm","type":"EX-10.1","id":"NTFILEC7jMsAGBufwDZmyz","market":"us","size":32731},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026029050/ea0281959-8k_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea0281959-8k_drugs2.htm","type":"8-K","id":"NTFILEDCBY8gsvsVxPq5WL","market":"us","size":36164},{"description":"ADDENDUM TO LETTER OF INTENT DATED MARCH 9, 2026","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026029050/ea028195901ex10-2.htm","primary":false,"translateUrl":"","linkName":"ea028195901ex10-2.htm","type":"EX-10.2","id":"NTFILEEpquKy9cpr2oETxN","market":"us","size":24000},{"description":"BRIDGE FINANCING CONVERTIBLE PROMISSORY NOTE DATED MARCH 11, 2026","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026029050/ea028195901ex10-3.htm","primary":false,"translateUrl":"","linkName":"ea028195901ex10-3.htm","type":"EX-10.3","id":"NTFILE8iXocCMEAXjMKdiU","market":"us","size":13234}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2026-03-18 04:01","pubTimestamp":1773777668,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20810363","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026024763-DMII","pdf_url":"","pub_time":1772773200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMII","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026024763/0001213900-26-024763-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"FORM 8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026024763/ea028047201-8k_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea028047201-8k_drugs2.htm","type":"8-K","id":"NTFILE22b7MC3fnDjFba8s","market":"us","size":31573}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2026-03-06 13:00","pubTimestamp":1772773200,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20808546","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390026024387-DMII","pdf_url":"","pub_time":1772773200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMII","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026024387/0001213900-26-024387-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390026024387/ea0280265-8k_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea0280265-8k_drugs2.htm","type":"8-K","id":"NTFILEFPZn67FJmQiQB9zs","market":"us","size":37493}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2026-03-06 13:00","pubTimestamp":1772773200,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20497254","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025112095-DMII","pdf_url":"","pub_time":1763442000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"DMII","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"Quarterly Report","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/0001213900-25-112095-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/ea0265078-10q_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea0265078-10q_drugs2.htm","type":"10-Q","id":"NTFILEFWgy3ptpem4sFsim","market":"us","size":458709},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/ea026507801ex31-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea026507801ex31-1_drugs2.htm","type":"EX-31.1","id":"NTFILEGfYLbLov4EGAFzYJ","market":"us","size":11978},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/ea026507801ex31-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea026507801ex31-2_drugs2.htm","type":"EX-31.2","id":"NTFILE4LhuMabvJXntHd9D","market":"us","size":11968},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/ea026507801ex32-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea026507801ex32-1_drugs2.htm","type":"EX-32.1","id":"NTFILE3Buo4FJjDJ489ngD","market":"us","size":4610},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025112095/ea026507801ex32-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea026507801ex32-2_drugs2.htm","type":"EX-32.2","id":"NTFILEww3tLTisfQkGtoT2","market":"us","size":4625}],"type_name":"Financial Report","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"财务报告","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"Quarterly Report","pubTime":"2025-11-18 13:00","pubTimestamp":1763442000,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20497251","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025111706-DMII","pdf_url":"","pub_time":1763442000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMII","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025111706/0001213900-25-111706-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025111706/ea0265998-8k_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea0265998-8k_drugs2.htm","type":"8-K","id":"NTFILE25oRbezbZjk4FjQ2","market":"us","size":47195}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-11-18 13:00","pubTimestamp":1763442000,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20497247","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025095513-DMII","pdf_url":"","pub_time":1759377600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMII","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025095513/0001213900-25-095513-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"BALANCE SHEET DATED SEPTEMBER 26, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025095513/ea025966201ex99-1_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea025966201ex99-1_drugs2.htm","type":"EX-99.1","id":"NTFILEAAA27QSyHwP3JTXw","market":"us","size":114250},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025095513/ea0259662-8k_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea0259662-8k_drugs2.htm","type":"8-K","id":"NTFILE3phmxEJ9FxAR9JAi","market":"us","size":18513}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-10-02 12:00","pubTimestamp":1759377600,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20224112","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025093224-DMII","pdf_url":"","pub_time":1759181333000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMII","title":"Form 8-K - Current report","titleType":"Major Issues Report","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/0001213900-25-093224-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"UNDERWRITING AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND BETWEEN THE COMPANY AND","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex1-1_drugs2.htm","primary":true,"translateUrl":"","linkName":"ea025896901ex1-1_drugs2.htm","type":"EX-1.1","id":"NTFILE91h2b3CiDY6bbbxG","market":"us","size":263251},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea0258969-8k_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea0258969-8k_drugs2.htm","type":"8-K","id":"NTFILECpPWdDL7ngeHKEWn","market":"us","size":45247},{"description":"AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex3-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex3-1_drugs2.htm","type":"EX-3.1","id":"NTFILE3habBRVesg3EUJWD","market":"us","size":286799},{"description":"RIGHTS AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND BETWEEN THE COMPANY AND CONTI","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex4-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex4-1_drugs2.htm","type":"EX-4.1","id":"NTFILE8zB2dsP7dqYC6iZ7","market":"us","size":68156},{"description":"LETTER AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND AMONG THE COMPANY, DRUGS MADE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-1_drugs2.htm","type":"EX-10.1","id":"NTFILE6FGWQwdP2H4r7wAi","market":"us","size":53854},{"description":"INVESTMENT MANAGEMENT TRUST AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND AMONG TH","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-2_drugs2.htm","type":"EX-10.2","id":"NTFILEEph96NTSg4q9Qnoe","market":"us","size":98263},{"description":"REGISTRATION RIGHTS AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND AMONG THE COMPAN","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-3_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-3_drugs2.htm","type":"EX-10.3","id":"NTFILEApgAHkW6PJGUZxr5","market":"us","size":105386},{"description":"PRIVATE UNITS SUBSCRIPTION AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND BETWEEN T","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-4_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-4_drugs2.htm","type":"EX-10.4","id":"NTFILEBCTERJ8ZYdg3CLcV","market":"us","size":28320},{"description":"PRIVATE UNITS SUBSCRIPTION AGREEMENT, DATED SEPTEMBER 24, 2025, BY AND BETWEEN T","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-5_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-5_drugs2.htm","type":"EX-10.5","id":"NTFILECccisa3Y8JEVT8BQ","market":"us","size":30246},{"description":"FORM OF INDEMNITY AGREEMENT BY AND BETWEEN THE COMPANY AND EACH OF THE OFFICERS","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-6_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-6_drugs2.htm","type":"EX-10.6","id":"NTFILE4YbLeUaFfBVUFiyA","market":"us","size":81365},{"description":"ADMINISTRATIVE SERVICES AGREEMENT, DATED AS OF SEPTEMBER 24, 2025, BY AND BETWEE","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex10-7_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex10-7_drugs2.htm","type":"EX-10.7","id":"NTFILE22eXsvrs1ULX2nfL","market":"us","size":10653},{"description":"PRESS RELEASE DATED SEPTEMBER 25, 2025","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex99-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex99-1_drugs2.htm","type":"EX-99.1","id":"NTFILE9KtkrrkqQ52Q844k","market":"us","size":7950},{"description":"PRESS RELEASE DATED SEPTEMBER 26, 2025","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ea025896901ex99-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea025896901ex99-2_drugs2.htm","type":"EX-99.2","id":"NTFILE9eydC7q9PCjpaEhP","market":"us","size":8483},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025093224/ex3-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex3-1_001.jpg","type":"GRAPHIC","id":"NTFILEFVMS7SRHEUQcoEYN","market":"us","size":12566}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Major Issues Report","pubTime":"2025-09-30 05:28","pubTimestamp":1759181333,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20710956","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025089923-DMII","pdf_url":"","pub_time":1758513600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMII","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025089923/0001213900-25-089923-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025089923/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEFrkDXuYmM6di1kFT","market":"us","size":10040}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2025-09-22 12:00","pubTimestamp":1758513600,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20710905","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025089929-DMII","pdf_url":"","pub_time":1758513600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMII","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025089929/0001213900-25-089929-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025089929/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE4ygUgQYaBeRQc3W3","market":"us","size":7333}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2025-09-22 12:00","pubTimestamp":1758513600,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20710910","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025088056-DMII","pdf_url":"","pub_time":1757995200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMII","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025088056/0001213900-25-088056-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025088056/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILEDMRgQM3mtm1JWx19","market":"us","size":10701},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025088056/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEHFUTows9Us3NG6n2","market":"us","size":3069}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2025-09-16 12:00","pubTimestamp":1757995200,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20175248","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025088044-DMII","pdf_url":"","pub_time":1757995200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMII","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025088044/0001213900-25-088044-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025088044/ea0234544-09.htm","primary":true,"translateUrl":"","linkName":"ea0234544-09.htm","type":"S-1/A","id":"NTFILE8eY3mGQXSc9VdwJe","market":"us","size":4594239},{"description":"FORM OF LETTER AGREEMENT AMONG THE REGISTRANT, ITS DIRECTORS AND OFFICERS, AND D","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025088044/ea023454409ex10-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023454409ex10-3_drugs.htm","type":"EX-10.3","id":"NTFILEDDZikXknjnFhkaqW","market":"us","size":49929}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2025-09-16 12:00","pubTimestamp":1757995200,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20170097","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025087444-DMII","pdf_url":"","pub_time":1757908800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMII","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/0001213900-25-087444-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/ea0234544-08.htm","primary":true,"translateUrl":"","linkName":"ea0234544-08.htm","type":"S-1/A","id":"NTFILEFSsdqzvwEsKsDGur","market":"us","size":4591246},{"description":"FORM OF UNDERWRITING AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/ea023454408ex1-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454408ex1-1_drugs2.htm","type":"EX-1.1","id":"NTFILEDLFBayWvssPm78kd","market":"us","size":252537},{"description":"OPINION OF MAPLES AND CALDER (CAYMAN) LLP","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/ea023454408ex5-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454408ex5-1_drugs2.htm","type":"EX-5.1","id":"NTFILEDea4x5sejXM35m17","market":"us","size":55574},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE6WRa3G1hZM2S42AC","market":"us","size":9247},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025087444/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILE7qBsppfRiaKmrjMw","market":"us","size":12840}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2025-09-15 12:00","pubTimestamp":1757908800,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20136176","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025085167-DMII","pdf_url":"","pub_time":1757044800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMII","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[Amend]Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/0001213900-25-085167-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ea0234544-06.htm","primary":true,"translateUrl":"","linkName":"ea0234544-06.htm","type":"S-1/A","id":"NTFILE2TAUASXtkgmdDQQb","market":"us","size":4565347},{"description":"FORM OF UNDERWRITING AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ea023454406ex1-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023454406ex1-1_drugs.htm","type":"EX-1.1","id":"NTFILE7x8wmGwmtF7BZD48","market":"us","size":250437},{"description":"OPINION OF MAPLES AND CALDER (CAYMAN) LLP","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ea023454406ex5-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454406ex5-1_drugs2.htm","type":"EX-5.1","id":"NTFILEEWEjbY6ARPZbG9sf","market":"us","size":39364},{"description":"OPINION OF LOEB & LOEB LLP","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ea023454406ex5-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454406ex5-2_drugs2.htm","type":"EX-5.2","id":"NTFILE9aDU6hDfR4F8ZopZ","market":"us","size":11529},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ea023454406ex23-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454406ex23-1_drugs2.htm","type":"EX-23.1","id":"NTFILEDZA5vghouTiMmW3g","market":"us","size":1909},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE5w4XddGU94m1GCMH","market":"us","size":11028},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILED5WPUJqthEWcYg3T","market":"us","size":12588},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025085167/ex5-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-2_001.jpg","type":"GRAPHIC","id":"NTFILEHpPyXaS17TdaRzFk","market":"us","size":12991}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[Amend]Public Prospectus","pubTime":"2025-09-05 12:00","pubTimestamp":1757044800,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20136178","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025065837-DMII","pdf_url":"","pub_time":1753070400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"DMII","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"Public Prospectus","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/0001213900-25-065837-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea0234544-04.htm","primary":true,"translateUrl":"","linkName":"ea0234544-04.htm","type":"S-1","id":"NTFILE755Uv9YP7QzD9uBd","market":"us","size":4544925},{"description":"MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex3-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex3-1_drugs2.htm","type":"EX-3.1","id":"NTFILEBssNQB3B5D9eC9dx","market":"us","size":239206},{"description":"FORM OF AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex3-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex3-2_drugs2.htm","type":"EX-3.2","id":"NTFILE2FdcuaPbUxXWj498","market":"us","size":283955},{"description":"SPECIMEN UNIT CERTIFICATE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex4-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex4-1_drugs2.htm","type":"EX-4.1","id":"NTFILE7gMyXmuR2hTPzkVi","market":"us","size":21282},{"description":"SPECIMEN ORDINARY SHARE CERTIFICATE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex4-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex4-2_drugs2.htm","type":"EX-4.2","id":"NTFILEAqJRkNqbx9kVLvsC","market":"us","size":20026},{"description":"FORM OF RIGHTS AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER & TRUST COMPANY AND","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex4-4_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex4-4_drugs2.htm","type":"EX-4.4","id":"NTFILE97Uu5fJzoF5zBbde","market":"us","size":68499},{"description":"PROMISSORY NOTE, DATED AS OF SEPTEMBER 5, 2024, AS AMENDED, ISSUED TO DRUGS MADE","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-1_drugs2.htm","type":"EX-10.1","id":"NTFILEHCjaudcTJvZvrHR6","market":"us","size":27200},{"description":"SECURITIES SUBSCRIPTION AGREEMENT, DATED SEPTEMBER 10, 2024, BETWEEN THE REGISTR","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-2_drugs2.htm","type":"EX-10.2","id":"NTFILEGxQTCsQEQLSVrWF3","market":"us","size":45653},{"description":"FORM OF LETTER AGREEMENT AMONG THE REGISTRANT, ITS DIRECTORS AND OFFICERS, AND D","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-3_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-3_drugs2.htm","type":"EX-10.3","id":"NTFILEJ5jcEmQwe3d8sMua","market":"us","size":44793},{"description":"FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT BETWEEN CONTINENTAL STOCK TRANSFER","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-4_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-4_drugs2.htm","type":"EX-10.4","id":"NTFILEAyuW6TrcE31YBJpe","market":"us","size":96880},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT AMONG THE REGISTRANT, DRUGS MADE IN AMERIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-5_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-5_drugs2.htm","type":"EX-10.5","id":"NTFILE7mz8ibWbjLevWLYV","market":"us","size":103172},{"description":"FORM OF PRIVATE UNITS PURCHASE AGREEMENT BETWEEN THE REGISTRANT AND DRUGS MADE I","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-6_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-6_drugs2.htm","type":"EX-10.6","id":"NTFILEGujztQdNTnGeZov5","market":"us","size":27395},{"description":"FORM OF PRIVATE UNITS PURCHASE AGREEMENT BETWEEN THE REGISTRANT AND CANTOR FITZG","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-7_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-7_drugs2.htm","type":"EX-10.7","id":"NTFILE5CBU3coNB3sRegJT","market":"us","size":28354},{"description":"FORM OF INDEMNITY AGREEMENT","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-8_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-8_drugs2.htm","type":"EX-10.8","id":"NTFILEFKbm5YebFv2GNapi","market":"us","size":81257},{"description":"FORM OF ADMINISTRATIVE SERVICES AGREEMENT BY AND BETWEEN THE REGISTRANT AND AN A","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex10-9_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex10-9_drugs2.htm","type":"EX-10.9","id":"NTFILEF9NsLyjLv8zXnPRR","market":"us","size":10757},{"description":"FORM OF CODE OF CONDUCT","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex14_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex14_drugs2.htm","type":"EX-14","id":"NTFILEAJq6NJSLGtxG3HR3","market":"us","size":49115},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex23-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex23-1_drugs2.htm","type":"EX-23.1","id":"NTFILE3WwRDHeAzWpy6UN6","market":"us","size":2144},{"description":"CONSENT OF CATHERINE DO","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex99-1_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex99-1_drugs2.htm","type":"EX-99.1","id":"NTFILE8YKa6Dcv7eAnws1b","market":"us","size":2188},{"description":"CONSENT OF G. SRIDHAR PRASAD","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex99-2_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex99-2_drugs2.htm","type":"EX-99.2","id":"NTFILEBbZZEr6AKmXQEdt4","market":"us","size":2104},{"description":"CONSENT OF MYRON W. SHULGAN","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex99-3_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex99-3_drugs2.htm","type":"EX-99.3","id":"NTFILEENA7BJxoNwPGoxt9","market":"us","size":2269},{"description":"FORM OF AUDIT COMMITTEE CHARTER","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex99-4_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex99-4_drugs2.htm","type":"EX-99.4","id":"NTFILE6ihi3tjp3woNgMet","market":"us","size":38650},{"description":"FORM OF COMPENSATION COMMITTEE CHARTER","seq":22,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex99-5_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex99-5_drugs2.htm","type":"EX-99.5","id":"NTFILEBTb3xyj7MNmUeko1","market":"us","size":31779},{"description":"FILING FEE TABLE","seq":23,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ea023454404ex-fee_drugs2.htm","primary":false,"translateUrl":"","linkName":"ea023454404ex-fee_drugs2.htm","type":"EX-FILING FEES","id":"NTFILEGvQVm6QjDuRYf3Qi","market":"us","size":20431},{"description":"GRAPHIC","seq":28,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ex3-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex3-1_001.jpg","type":"GRAPHIC","id":"NTFILEHfpABtJGntSwaaqQ","market":"us","size":9129},{"description":"GRAPHIC","seq":29,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065837/ex3-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex3-1_002.jpg","type":"GRAPHIC","id":"NTFILEB9UbYUjheeL1ya7V","market":"us","size":7198}],"type_name":"Recruitment Registration","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"招股注册","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"Public Prospectus","pubTime":"2025-07-21 12:00","pubTimestamp":1753070400,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20710927","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025065839-DMII","pdf_url":"","pub_time":1752811200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMII","title":"Form CORRESP - Correspondence","titleType":"Correspondence","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065839/0001213900-25-065839-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065839/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE2K37663UEZwFhs2J","market":"us","size":8337},{"description":"GRAPHIC","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2040475/000121390025065839/image_001.jpg","primary":false,"translateUrl":"","linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEBCLBs1yw6JnaNy1f","market":"us","size":9366}],"type_name":"Transaction Related","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"交易披露","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"Correspondence","pubTime":"2025-07-18 12:00","pubTimestamp":1752811200,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}